tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher Raymond, 361 are a BUY (79.52%), 87 are a HOLD (19.16%), 6 are a SELL (1.32%).
Analyst Christopher Raymond works at PIPER SANDLER with a stock forecast success ratio of 49.12% fulfilled within 217.25 days on average.
Christopher Raymond’s has documented 897 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BOLD, Audentes Therapeutics at 22-Apr-2024.
Analyst best performing recommendations are on ALXO (ALX ONCOLOGY HOLDINGS ).
The best stock recommendation documented was for DCPH (DECIPHERA PHARMACEUTICALS LLC) at 5/31/2018. The price target of $35 was fulfilled within 4 days with a profit of $9.28 (36.08%) receiving and performance score of 90.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
195
$27.2 (16.21%)
185
29 days ago
10/12 (83.33%)
$14.65 (8.12%)
191
Buy
189
$21.2 (12.63%)
181
2 months 19 days ago
9/11 (81.82%)
$15.71 (9.07%)
252
Buy
195
$27.2 (16.21%)
180
2 months 19 days ago
9/10 (90%)
$21.71 (12.53%)
445
Hold
165
$-2.8 (-1.67%)
157
3 months 8 days ago
11/11 (100%)
$2.96 (1.83%)
314
Buy
180
$12.2 (7.27%)
195
3 months 22 days ago
3/5 (60%)
$21.06 (13.25%)
496
Which stock is Christopher Raymond is most bullish on?
Which stock is Christopher Raymond is most reserved on?
What Year was the first public recommendation made by Christopher Raymond?
